TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/19/24 18:44 | 3/18/24 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moxie Dwight | TN | O | CLO,GC | S | -41 | 5.04 | 0 | -8 | -6 | 138 | D | ||||||||||||||
9/7/23 17:37 | 9/5/23 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moxie Dwight | TN | O | SVP,GC,S | S.m | -613 | 17.58 | 0 | -35 | -44 | 44 | D | ||||||||||||||
5/16/23 20:29 | 5/15/23 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moxie Dwight | TN | O | SVP,GC,S | S | -739 | 34.55 | 0 | -21 | -24 | 69 | D | ||||||||||||||
3/9/23 21:46 | 3/9/23 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moxie Dwight | TN | O | SVP,GC,S | S | -584 | 31.59 | 0 | -18 | -25 | 56 | D | ||||||||||||||
9/16/22 16:55 | 9/14/22 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moxie Dwight | TN | O | SVP,GC,S | S | -298 | 27.07 | 0 | -11 | -26 | 32 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |